# Ye Xiaoli

> Ye Xiaoli is a Series B investor at Hongtai Fund backing Health Care and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Hongtai Fund](https://shizune.co/investors/profile/hongtai-fund)
- Total investments: 1
- Last investment: Mar 2022
- Lead investor: 0%
- Last updated: Aug 2026

Ye Xiaoli is a Series B investor at Hongtai Fund focused on Health Care and Biotechnology. Ye Xiaoli

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| CytoNiche | CytoNiche focuses on the development of 3D micro-organization engineering technology. The core technology is derived from the transformation of Tsinghua University's achievements. Based on its original research technology, Huasheng Bio has launched a series of related products and services, including customized, large-scale, automated andintelligent stem cell culture. Amplification process; 3D stem cell micro-tissue regeneration treatment of new drugs and 3D cell high-throughput drug screening products. | $47.5M | Series B | Mar 03, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Gaorong Capital](https://shizune.co/investors/profile/banyan-capital) — VC Fund, 2 deals together
- [CICC Qide](https://shizune.co/investors/profile/cicc-qide) — VC Fund, 2 deals together
- [3E Bioventures](https://shizune.co/investors/profile/3e-bioventures) — VC Fund, 1 deal together
- [Aibo Qingshi Venture Capital Fund](https://shizune.co/investors/profile/aibo-qingshi-venture-capital-fund) — VC Fund, 1 deal together
- [Hongtai Capital Holdings](https://shizune.co/investors/profile/aplus-capital) — VC Fund, 1 deal together
- [Bencao Capital](https://shizune.co/investors/profile/bencao-capital) — VC Fund, 1 deal together

## About Hongtai Fund

VC Fund · Shenzhen, China

Hongtai Fund provides funding and management support for companies.

3 contacts available at Hongtai Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Jin Chuan | Vice President | https://shizune.co/investors/profile/jin-chuan |
| Ye Xiaoli | Executive Director | https://shizune.co/investors/profile/ye-xiaoli |
| Zhou Guangtao | Managing Director | https://shizune.co/investors/profile/zhou-guangtao |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Ye Xiaoli invest in?

Ye Xiaoli invests primarily in Health Care and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ye Xiaoli last invest?

The most recent investment recorded for Ye Xiaoli closed in Mar 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co